United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp at Cowen Healthcare Conference (Virtual) Transcript

Mar 03, 2021 / 03:20PM GMT
Release Date Price: €136 (-4.23%)
Joseph John;Charles Thome
Cowen and Company, LLC, Research Division - VP of Healthcare

Hi, everyone, and thank you for joining us at Cowen and Company's 41st Annual Healthcare Conference. I'm Joe Thome, the senior biotech analyst on the team. And it is my pleasure to have with me today the team from United Therapeutics, Mike Benkowitz, President and CEO; James Edgemond, CFO and Treasurer; and the Head of Investor Relations, Dewey Steadman. To kick things off, I will turn it over to Dewey, who has some forward-looking statements to announce.

Dewey Steadman
United Therapeutics Corporation - Head of IR

Hi, good morning. Our remarks today may include forward-looking information about our business, and please see our SEC filings for risks and uncertainties that could cause actual results to differ. Thanks, Joe.

Joseph John;Charles Thome
Cowen and Company, LLC, Research Division - VP of Healthcare

Great. And Michael, just to start with you. Definitely been a lot of progress over the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot